Scientific article: Irinotecan is active against colorectal cancer in patients whose disease is refractory to fluorouracil. We investigated the efficacy of these two agents combined for first-line treatment of metastatic colorectal cancer. | Archive institutionnelle de l'Université de Genève - Institutional Repository of the University of Geneva
No takes yet. Share an insight, caveat, or question.
Douillard et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: